Back to search

Article

Pre-clinical validation of a novel pan-cancer CAR-T cell immunotherapy against nfP2X7

2021-12-01

Abstract excerpt

<title>Abstract</title> <p>Chimeric antigen receptor (CAR)-T immunotherapy is a novel treatment that genetically modifies the patient’s own T cells to target and kill malignant cells. CAR-T cells demonstrated robust clinical activity against certain B-cell malignancies. However, identification of tumour-specific antigens expressed on multiple cancer types, especially on solid cancers, remains a major challenge. P...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b356c833-bf0c-57c7-af24-b9a0ac7f594f
DOI
10.21203/rs.3.rs-1073214/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pre-clinical validation of a novel pan-cancer CAR-T cell immunotherapy against nfP2X7DOI 10.21203/rs.3.rs-1073214/v1
Select a neighboring publication to make it the new centre.